Molecular genetics of essential hypertension
- 28 March 2016
- journal article
- review article
- Published by Taylor & Francis Ltd in Clinical and Experimental Hypertension
- Vol. 38 (3), 268-277
- https://doi.org/10.3109/10641963.2015.1116543
Abstract
Hypertension is a major public health problem in the developing as well as in developed countries due to its high prevalence and its association with coronary heart disease, renal disease, stroke, peripheral vascular disease, and related disorders. Essential hypertension (EH) is the most common diagnosis in this disease, suggesting that a monocausal etiology has not been identified. However, a number of risk factors associated with EH have also been identified such as age, sex, demographic, environmental, genetic, and vascular factors. Recent advances in molecular biological research had achieved clarifying the molecular basis of Mendelian hypertensive disorders. Molecular genetic studies have now identified mutations in several genes that cause Mendelian forms of hypertension in humans. However, none of the single genetic variants has emerged from linkage or association analyses as consistently related to the blood pressure level in every sample and in all populations. Besides, a number of polymorphisms in candidate genes have been associated with differences in blood pressure. The most prominent candidate has been the polymorphisms in the renin–angiotensin–aldosterone system. In total, EH is likely to be a polygenic disorder that results from inheritance of a number of susceptibility genes and involves multiple environmental determinants. These determinants complicate the study of blood pressure variations in the general population. The complex nature of the hypertension phenotype makes large-scale studies indispensable, when screening of familial and genetic factors was intended. In this review, recent genetic studies exploring the molecular basis of EH, including different molecular pathways, are highlighted.Keywords
Funding Information
- University Grant Commission – Junior Research Fellowship contingency (JRF in Centre for Experimental Medicine and Surgery (C.E.M.S.); No.-R/Dev. (JRF-SRF)/“R”A/c /Medicine/23069)
- University Grants Commission (No.-F.4/2006 (BSR)/13-581 and 604/2012(BSR))
This publication has 99 references indexed in Scilit:
- Genome-Wide Association Studies: Contribution of Genomics to Understanding Blood Pressure and Essential HypertensionCurrent Hypertension Reports, 2010
- Genotype–phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypesJournal of Hypertension, 2010
- Genome-wide association study of blood pressure and hypertensionNature Genetics, 2009
- Genome-wide association study identifies eight loci associated with blood pressureNature Genetics, 2009
- Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control studyImmunity & Ageing, 2008
- Genetic association analysis of inositol polyphosphate phosphatase-like 1 (INPPL1, SHIP2) variants with essential hypertensionJournal of Medical Genetics, 2007
- Genetic dissection of complex traits: guidelines for interpreting and reporting linkage resultsNature Genetics, 1995
- Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndromeNature Genetics, 1995
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990